We are live on
!
Find out more
EAM
EFG Asset Management Portfolio holdings
AUM
$773M
1-Year Est. Return
40.1%
This Fund
S&P 500
This Quarter
Est. Return
-8.89%
1 Year Est. Return
+40.1%
3 Year Est. Return
+211.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$602M
AUM Growth
-$131M
(-18%)
Cap. Flow
-$51M
Cap. Flow
% of AUM
-8.48%
Top 10 Holdings %
Top 10 Hldgs %
19.62%
Holding
196
New
22
Increased
46
Reduced
108
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$6.99M |
| 2 |
Semtech
SMTC
|
+$4.05M |
| 3 |
Marvell Technology
MRVL
|
+$3.94M |
| 4 |
Protagonist Therapeutics
PTGX
|
+$2.98M |
| 5 |
Birkenstock
BIRK
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$7.41M |
| 2 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$6.2M |
| 3 |
Shift4
FOUR
|
+$3.98M |
| 4 |
Roivant Sciences
ROIV
|
+$3.82M |
| 5 |
Alkermes
ALKS
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.07% |
| 2 | Healthcare | 26.2% |
| 3 | Industrials | 12.62% |
| 4 | Consumer Discretionary | 12.17% |
| 5 | Financials | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Rocket Pharmaceuticals
RCKT
$375M
| $737K | 0.12% |
110,961
-34,668
| -24% | -$343K |
|
177
Accenture
ACN
$103B
| – | – |
-8,895
| Closed | -$3.13M |
|
|
178
Alkermes
ALKS
$8.41B
| – | – |
-129,662
| Closed | -$3.73M |
|
179
Advanced Micro Devices
AMD
$790B
| – | – |
-22,322
| Closed | -$2.7M |
|
180
Boise Cascade
BCC
$2.83B
| – | – |
-18,220
| Closed | -$2.17M |
|
181
Boston Scientific
BSX
$71.4B
| – | – |
-29,930
| Closed | -$2.67M |
|
182
Charles River Laboratories
CRL
$11.1B
| – | – |
-8,959
| Closed | -$1.65M |
|
|
FL
183
DELISTED
Foot Locker
FL
| – | – |
-106,448
| Closed | -$2.32M |
|
|
184
Shift4
FOUR
$4.32B
| – | – |
-38,297
| Closed | -$3.98M |
|
|
HEES
185
DELISTED
H&E Equipment Services
HEES
| – | – |
-50,484
| Closed | -$2.47M |
|
186
Intuit
INTU
$88B
| – | – |
-4,413
| Closed | -$2.77M |
|
187
nCino
NCNO
$2.11B
| – | – |
-70,739
| Closed | -$2.38M |
|
188
PubMatic
PUBM
$594M
| – | – |
-133,756
| Closed | -$1.96M |
|
|
189
Roivant Sciences
ROIV
$23.9B
| – | – |
-322,734
| Closed | -$3.82M |
|
190
Rapid7
RPD
$686M
| – | – |
-58,383
| Closed | -$2.35M |
|
191
SentinelOne
S
$6.88B
| – | – |
-117,748
| Closed | -$2.61M |
|
192
Selective Insurance
SIGI
$5.66B
| – | – |
-24,060
| Closed | -$2.25M |
|
193
ScottsMiracle-Gro
SMG
$3.99B
| – | – |
-40,028
| Closed | -$2.66M |
|
194
Veeco
VECO
$3.07B
| – | – |
-116,182
| Closed | -$3.12M |
|
|
GAP
195
The Gap Inc
GAP
$7.29B
| – | – |
-69,728
| Closed | -$1.65M |
|
|
ITCI
196
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
-74,190
| Closed | -$6.2M |
|
Similar funds
HWM
CP
BVDMP
MSAM
WA
PAS
NSEDCP
RAM
EFG Asset Management's Q1 2025 Portfolio in Review
As of Q1 2025, EFG Asset Management held 196 positions worth $602M, down 18% from $732M the previous quarter. Its ten largest holdings account for 20% of the portfolio.
EFG Asset Management withdrew a net $51M in Q1 2025, closing 20 positions and reducing 108 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $6.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 30% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, EFG Asset Management opened a new position in Semtech worth $2.82M.
- EFG Asset Management's largest Q1 2025 buy was Semtech: 82,076 shares worth $2.82M.
- EFG Asset Management added most to Eli Lilly in Q1 2025, an estimated $6.99M increase.
- EFG Asset Management's biggest Q1 2025 reduction was Apple, cutting an estimated $7.41M.
- EFG Asset Management fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $6.2M.
- EFG Asset Management's ten largest holdings make up 20% of its $602M portfolio in Q1 2025.
- EFG Asset Management opened 22 new positions and closed 20 in Q1 2025.
- EFG Asset Management's portfolio value fell 18% quarter-over-quarter to $602M.
Based on EFG Asset Management's 13F filing for Q1 2025, filed 15 May 2025.